As of 2025-10-17, the Relative Valuation of KemPharm Inc (KMPH) is (20.29) USD. This relative valuation is based on P/E multiples. With the latest stock price at 5.81 USD, the upside of KemPharm Inc based on Relative Valuation is -449.2%.
The range of the Relative Valuation is (19.72) - (22.47) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 13.9x - 18.7x | 16.1x |
| Forward P/E multiples | 16.4x - 19.0x | 17.6x |
| Fair Price | (19.72) - (22.47) | (20.29) |
| Upside | -439.4% - -486.7% | -449.2% |
| Date | P/E |